Wuhan Easy Diagnosis Biomedicine Co (SZSE:002932) 3-Year Revenue Growth Rate : -10.50% (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Wuhan Easy Diagnosis Biomedicine Co 3-Year Revenue Growth Rate?

Wuhan Easy Diagnosis Biomedicine Co's Revenue per Share for the three months ended in Mar. 2024 was ¥0.27.

During the past 12 months, Wuhan Easy Diagnosis Biomedicine Co's average Revenue per Share Growth Rate was -95.30% per year. During the past 3 years, the average Revenue per Share Growth Rate was -10.50% per year. During the past 5 years, the average Revenue per Share Growth Rate was 71.80% per year. During the past 10 years, the average Revenue per Share Growth Rate was 33.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Wuhan Easy Diagnosis Biomedicine Co was 274.80% per year. The lowest was -32.90% per year. And the median was 16.60% per year.

Competitive Comparison of Wuhan Easy Diagnosis Biomedicine Co's 3-Year Revenue Growth Rate

For the Medical Devices subindustry, Wuhan Easy Diagnosis Biomedicine Co's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Wuhan Easy Diagnosis Biomedicine Co's 3-Year Revenue Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Wuhan Easy Diagnosis Biomedicine Co's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Wuhan Easy Diagnosis Biomedicine Co's 3-Year Revenue Growth Rate falls into.

Wuhan Easy Diagnosis Biomedicine Co 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Wuhan Easy Diagnosis Biomedicine Co (SZSE:002932) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Wuhan Easy Diagnosis Biomedicine Co 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Wuhan Easy Diagnosis Biomedicine Co's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Wuhan Easy Diagnosis Biomedicine Co (SZSE:002932) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Wuhan Easy Diagnosis Biomedicine Co Ltd (SZSE:002932) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1 Dongxin Road, 2 Floor, Building E, International Students Pioneer Park, Guandong Science and Technology Park, Donghu Development Zone, Hubei, Wuhan, CHN, 430075

Website

http://www.mdeasydiagnosis.com

Wuhan Easy Diagnosis Biomedicine Co Ltd is engaged in the research and development, production and sales of in vitro diagnostic reagents and supporting instruments and mobile ECG products. The company's product profile consists of Molecular diagnosis, Chemiluminescence, Blood gas analysis, and others. It also provides various other solutions such as Mingde Biomolecular Diagnostic Service Solution, Mingde Biothoracic Center Solution, POCT Solution, Remote ECG network construction solution, and others.

Executives

Wang Rui	Directors, executives
Wang Jian Fei	Director

Wuhan Easy Diagnosis Biomedicine Co (SZSE:002932) Headlines

No Headlines